Clinical Trial Update: Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS) [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluating domperidone in relapsing-remitting multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Relapsing-remitting

Drugs mentioned

• Domperidone (domperidone)

Snippet

Sponsor: University of Calgary | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 2 | Status: COMPLETED